Overview Safety and Efficacy of Long-term Somatropin Treatment in Adults Status: Completed Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (Norditropin®). Details Lead Sponsor: Novo Nordisk A/S